Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.7064781204617545e-34,21.709440057430008,1671.1451743018567,"['RPL30', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.375891459718892e-32,0,0,65
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.300172018003231e-21,19.605988967691097,911.9472854084187,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5']",6.268671157913215e-19,0,0,40
3,Nonalcoholic fatty liver disease WP4396,2.0475190114651954e-18,16.198356807511736,659.7574991316935,"['NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS']",1.3581876109385796e-16,0,0,37
4,Oxidative phosphorylation WP623,3.4116654058336175e-10,12.678733031674208,276.3792684801247,"['ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.6973035394022248e-08,0,0,21
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.45389558282855e-10,23.7847533632287,507.3173913641552,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5']",2.1706504419657624e-08,0,0,17
6,Mitochondrial CIV Assembly WP4922,5.239725366771765e-07,11.661469933184856,168.64615566575196,"['COX8A', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14']",1.7378422466459685e-05,0,0,14
7,Pyrimidine metabolism WP4022,0.0001353200443524907,6.494310998735777,57.85046438922983,"['POLD4', 'RRM2', 'UCK1', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.0038469555465922354,0,0,11
8,Mitochondrial complex III assembly WP4921,0.0011398301832116985,12.295404814004376,83.32443366848803,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.028353275807391002,0,0,6
9,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.026337275555633907,12.221739130434782,44.447654483134954,"['LPL', 'FOXO4', 'NDRG1']",0.5564710990076275,0,0,3
10,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.03914872053319993,inf,inf,"['COX8A', 'GSTP1']",0.5564710990076275,0,0,2
11,Dual hijack model of Vif in HIV infection WP3300,0.03914872053319993,inf,inf,"['ELOB', 'ELOC']",0.5564710990076275,0,0,2
12,Fluoropyrimidine Activity WP1601,0.03914872053319993,inf,inf,"['RRM2', 'UCK1']",0.5564710990076275,0,0,2
13,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.03914872053319993,inf,inf,"['ELOB', 'ELOC']",0.5564710990076275,0,0,2
14,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.03914872053319993,inf,inf,"['HEXIM1', 'SUPT4H1']",0.5564710990076275,0,0,2
15,Proteasome Degradation WP183,0.06946237215846603,2.913287585776669,7.769650828083031,"['PSMB6', 'PSMD7', 'H2AFZ', 'PSME1', 'PSMB10']",0.921534137302316,0,0,5
16,Cellular Proteostasis WP4918,0.10199465621786018,8.130151843817787,18.559794022511937,"['PFDN5', 'PFDN6']",0.9997324946750447,0,0,2
17,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.10199465621786018,8.130151843817787,18.559794022511937,"['PTTG1', 'ANAPC11']",0.9997324946750447,0,0,2
18,Cytosolic DNA-sensing pathway WP4655,0.1443671146837593,3.0505434782608694,5.904009084677555,"['IL18', 'POLR2K', 'POLR2L']",0.9997324946750447,0,0,3
19,Modulators of TCR signaling and T cell activation WP5072,0.1443671146837593,3.0505434782608694,5.904009084677555,"['NDUFB10', 'ELOB', 'RNF7']",0.9997324946750447,0,0,3
20,Hypertrophy Model WP516,0.17765207080268242,4.06290672451193,7.020411509299629,"['WDR1', 'IL18']",0.9997324946750447,0,0,2
21,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.17765207080268242,4.06290672451193,7.020411509299629,"['ACTA2', 'ACTC1']",0.9997324946750447,0,0,2
22,Nucleotide metabolism WP404,0.17765207080268242,4.06290672451193,7.020411509299629,"['RRM2', 'NME2']",0.9997324946750447,0,0,2
23,PPAR signaling pathway WP3942,0.17765207080268242,4.06290672451193,7.020411509299629,"['FABP7', 'LPL']",0.9997324946750447,0,0,2
24,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.17765207080268242,4.06290672451193,7.020411509299629,"['ACTA2', 'NOS1']",0.9997324946750447,0,0,2
25,Regulation of Microtubule Cytoskeleton WP2038,0.17765207080268242,4.06290672451193,7.020411509299629,"['PARD6A', 'CFL2']",0.9997324946750447,0,0,2
26,Serotonin Transporter Activity WP1455,0.19803225879245867,inf,inf,['NOS1'],0.9997324946750447,0,0,1
27,Statin inhibition of cholesterol production WP430,0.19803225879245867,inf,inf,['LPL'],0.9997324946750447,0,0,1
28,Composition of Lipid Particles WP3601,0.19803225879245867,inf,inf,['LPL'],0.9997324946750447,0,0,1
29,Hippo-Yap signaling pathway WP4537,0.19803225879245867,inf,inf,['NDRG1'],0.9997324946750447,0,0,1
30,let-7 inhibition of ES cell reprogramming WP3299,0.19803225879245867,inf,inf,['EGR1'],0.9997324946750447,0,0,1
31,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.19803225879245867,inf,inf,['HEY1'],0.9997324946750447,0,0,1
32,MTHFR deficiency WP4288,0.19803225879245867,inf,inf,['CYCS'],0.9997324946750447,0,0,1
33,NO metabolism in cystic fibrosis WP4947,0.19803225879245867,inf,inf,['NOS1'],0.9997324946750447,0,0,1
34,Pyrimidine metabolism and related diseases WP4225,0.19803225879245867,inf,inf,['RRM2'],0.9997324946750447,0,0,1
35,Amyotrophic lateral sclerosis (ALS) WP2447,0.19847759536921622,2.4391304347826086,3.9442667382601013,"['NEFM', 'NOS1', 'NEFH']",0.9997324946750447,0,0,3
36,mRNA Processing WP411,0.1997634441633109,2.033769063180828,3.2756319588409,"['LSM7', 'NCBP2', 'SRSF9', 'LSM2']",0.9997324946750447,0,0,4
37,Pre-implantation embryo WP3527,0.25638123987669564,2.0315217391304348,2.765083363253818,"['EGR1', 'ARGFX', 'DDIT3']",0.9997324946750447,0,0,3
38,Striated Muscle Contraction Pathway WP383,0.25860401557900364,2.707158351409978,3.661316032976736,"['ACTA2', 'ACTC1']",0.9997324946750447,0,0,2
39,Type 2 papillary renal cell carcinoma WP4241,0.25860401557900364,2.707158351409978,3.661316032976736,"['ELOB', 'ELOC']",0.9997324946750447,0,0,2
40,DNA Mismatch Repair WP531,0.25860401557900364,2.707158351409978,3.661316032976736,"['POLD4', 'POLE3']",0.9997324946750447,0,0,2
41,Nanomaterial induced apoptosis WP2507,0.25860401557900364,2.707158351409978,3.661316032976736,"['ENDOG', 'CYCS']",0.9997324946750447,0,0,2
42,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.29474603829648527,1.6252723311546842,1.985499609345457,"['NEFM', 'NOS1', 'NEFH', 'PFN2']",0.9997324946750447,0,0,4
43,Acute viral myocarditis WP4298,0.31612468038095015,1.7403726708074534,2.004245512606731,"['ENDOG', 'CYCS', 'NOS1']",0.9997324946750447,0,0,3
44,Eukaryotic Transcription Initiation WP405,0.31612468038095015,1.7403726708074534,2.004245512606731,"['POLR2I', 'POLR2J', 'POLR2K']",0.9997324946750447,0,0,3
45,Selenium Micronutrient Network WP15,0.31829982698591136,1.4511852776044916,1.661261018118327,"['SELENOM', 'PRDX5', 'SELENOW', 'TXN', 'SELENOH']",0.9997324946750447,0,0,5
46,Copper homeostasis WP3286,0.33979885983933406,2.029284164859002,2.1904122195575964,"['COX17', 'ATOX1']",0.9997324946750447,0,0,2
47,NO/cGMP/PKG mediated Neuroprotection WP4008,0.33979885983933406,2.029284164859002,2.1904122195575964,"['CYCS', 'NOS1']",0.9997324946750447,0,0,2
48,Nucleotide Excision Repair WP4753,0.33979885983933406,2.029284164859002,2.1904122195575964,"['POLD4', 'POLE3']",0.9997324946750447,0,0,2
49,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.33979885983933406,2.029284164859002,2.1904122195575964,"['NDUFA13', 'IL18']",0.9997324946750447,0,0,2
50,Prostaglandin Synthesis and Regulation WP98,0.33979885983933406,2.029284164859002,2.1904122195575964,"['S100A6', 'MITF']",0.9997324946750447,0,0,2
51,Biomarkers for pyrimidine metabolism disorders WP4584,0.35691570112799675,4.0562770562770565,4.179002381073887,['RRM2'],0.9997324946750447,0,0,1
52,Effects of nitric oxide WP1995,0.35691570112799675,4.0562770562770565,4.179002381073887,['NOS1'],0.9997324946750447,0,0,1
53,Fatty acid transporters WP5061,0.35691570112799675,4.0562770562770565,4.179002381073887,['FABP7'],0.9997324946750447,0,0,1
54,Gastric Cancer Network 2 WP2363,0.35691570112799675,4.0562770562770565,4.179002381073887,['S100A6'],0.9997324946750447,0,0,1
55,Glycerophospholipid Biosynthetic Pathway WP2533,0.35691570112799675,4.0562770562770565,4.179002381073887,['PTPMT1'],0.9997324946750447,0,0,1
56,GPR40 Pathway WP3958,0.35691570112799675,4.0562770562770565,4.179002381073887,['PLCH1'],0.9997324946750447,0,0,1
57,Homologous recombination WP186,0.35691570112799675,4.0562770562770565,4.179002381073887,['POLD4'],0.9997324946750447,0,0,1
58,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.35691570112799675,4.0562770562770565,4.179002381073887,['LPL'],0.9997324946750447,0,0,1
59,Alzheimer's disease WP2059,0.39396489963453585,1.3529411764705883,1.2602558588304709,"['ATP5MD', 'LPL', 'CYCS', 'NOS1']",0.9997324946750447,0,0,4
60,Ciliary landscape WP4352,0.41790366644925825,1.1839364035087718,1.0329896456784595,"['PSMD7', 'EXOSC4', 'NDUFA5', 'SSNA1', 'TTC30A', 'NEFM', 'COX6C']",0.9997324946750447,0,0,7
61,AGE/RAGE pathway WP2324,0.41797153038460366,1.6225596529284165,1.4154268644526726,"['CYCS', 'FOXO4']",0.9997324946750447,0,0,2
62,Parkinson's disease pathway WP2371,0.41797153038460366,1.6225596529284165,1.4154268644526726,"['CYCS', 'PARK7']",0.9997324946750447,0,0,2
63,Genotoxicity pathway WP4286,0.4348091832832144,1.3521739130434782,1.126155343527105,"['ACTA2', 'PLK3', 'RPS27']",0.9997324946750447,0,0,3
64,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4385483136800077,1.0748843357567746,0.8860113505103031,"['EGR1', 'SDF2L1', 'SSR4', 'FOXO4', 'TXN', 'RPL10A', 'BMX', 'NDRG1', 'RPL7', 'RPL18A', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'CHAC1', 'TMSB10', 'PTMA']",0.9997324946750447,0,0,18
65,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4843761410610457,2.027056277056277,1.469399966275067,['EGR1'],0.9997324946750447,0,0,1
66,Fatty acid beta-oxidation WP143,0.4843761410610457,2.027056277056277,1.469399966275067,['LPL'],0.9997324946750447,0,0,1
67,Heart Development WP1591,0.4843761410610457,2.027056277056277,1.469399966275067,['HEY1'],0.9997324946750447,0,0,1
68,IL1 and megakaryocytes in obesity WP2865,0.4843761410610457,2.027056277056277,1.469399966275067,['IL18'],0.9997324946750447,0,0,1
69,Major receptors targeted by epinephrine and norepinephrine WP4589,0.4843761410610457,2.027056277056277,1.469399966275067,['ADRA2C'],0.9997324946750447,0,0,1
70,Matrix Metalloproteinases WP129,0.4843761410610457,2.027056277056277,1.469399966275067,['MMP15'],0.9997324946750447,0,0,1
71,Monoamine Transport WP727,0.4843761410610457,2.027056277056277,1.469399966275067,['NOS1'],0.9997324946750447,0,0,1
72,Overview of nanoparticle effects WP3287,0.4843761410610457,2.027056277056277,1.469399966275067,['LAMA3'],0.9997324946750447,0,0,1
73,22q11.2 copy number variation syndrome WP4657,0.4908204076944776,1.1584189231248054,0.8244200883606384,"['ACTA2', 'RANBP1', 'MRPL40', 'ACTC1']",0.9997324946750447,0,0,4
74,Base Excision Repair WP4752,0.49113613894297714,1.351409978308026,0.9608983356150331,"['POLD4', 'POLE3']",0.9997324946750447,0,0,2
75,CAMKK2  Pathway WP4874,0.49113613894297714,1.351409978308026,0.9608983356150331,"['FIS1', 'NOS1']",0.9997324946750447,0,0,2
76,Vitamin A and carotenoid metabolism WP716,0.49113613894297714,1.351409978308026,0.9608983356150331,"['RBP2', 'LPL']",0.9997324946750447,0,0,2
77,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.49113613894297714,1.351409978308026,0.9608983356150331,"['PPP1CC', 'DDIT3']",0.9997324946750447,0,0,2
78,IL-18 signaling pathway WP4754,0.5174950652047733,1.0421648835745752,0.6865316298196255,"['ACTA2', 'ARL4D', 'NRN1', 'UCK1', 'IMP3', 'COX17', 'IL18', 'CYCS', 'NDUFC1']",0.9997324946750447,0,0,9
79,DNA Repair Pathways Full Network WP4946,0.5450045919833427,1.1051383399209487,0.6707759368049303,"['POLD4', 'CENPX', 'POLE3']",0.9997324946750447,0,0,3
80,Apoptosis Modulation by HSP70 WP384,0.586617417663253,1.3506493506493507,0.7204126331415429,['CYCS'],0.9997324946750447,0,0,1
81,Cardiac Progenitor Differentiation WP2406,0.586617417663253,1.3506493506493507,0.7204126331415429,['ACTC1'],0.9997324946750447,0,0,1
82,Triacylglyceride synthesis WP325,0.586617417663253,1.3506493506493507,0.7204126331415429,['LPL'],0.9997324946750447,0,0,1
83,TYROBP causal network in microglia WP3945,0.586617417663253,1.3506493506493507,0.7204126331415429,['IL18'],0.9997324946750447,0,0,1
84,Unfolded protein response WP4925,0.586617417663253,1.3506493506493507,0.7204126331415429,['DDIT3'],0.9997324946750447,0,0,1
85,Urea cycle and associated pathways WP4595,0.586617417663253,1.3506493506493507,0.7204126331415429,['NOS1'],0.9997324946750447,0,0,1
86,Development and heterogeneity of the ILC family WP3893,0.586617417663253,1.3506493506493507,0.7204126331415429,['IL18'],0.9997324946750447,0,0,1
87,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.586617417663253,1.3506493506493507,0.7204126331415429,['FOXO4'],0.9997324946750447,0,0,1
88,RAS and bradykinin pathways in COVID-19 WP4969,0.586617417663253,1.3506493506493507,0.7204126331415429,['NOS1'],0.9997324946750447,0,0,1
89,Integrated breast cancer pathway WP1984,0.5951854964195432,1.0125,0.5253681903765267,"['PLK3', 'FAU', 'FOSL2']",0.9997324946750447,0,0,3
90,NRF2 pathway WP2884,0.6606655636358989,0.8990559186637618,0.3726654412850427,"['EGR1', 'GSTP1', 'TXN', 'SLC5A3']",0.9997324946750447,0,0,4
91,Transcriptional cascade regulating adipogenesis WP4211,0.6686206881626044,1.0124458874458875,0.4075483101223271,['DDIT3'],0.9997324946750447,0,0,1
92,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6686206881626044,1.0124458874458875,0.4075483101223271,['CD63'],0.9997324946750447,0,0,1
93,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6686206881626044,1.0124458874458875,0.4075483101223271,['H2AFZ'],0.9997324946750447,0,0,1
94,Gastric Cancer Network 1 WP2361,0.6686206881626044,1.0124458874458875,0.4075483101223271,['CCNA1'],0.9997324946750447,0,0,1
95,Glycosylation and related congenital defects WP4521,0.6686206881626044,1.0124458874458875,0.4075483101223271,['MPDU1'],0.9997324946750447,0,0,1
96,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6686206881626044,1.0124458874458875,0.4075483101223271,['DDIT3'],0.9997324946750447,0,0,1
97,Methionine De Novo and Salvage Pathway WP3580,0.6686206881626044,1.0124458874458875,0.4075483101223271,['TXN'],0.9997324946750447,0,0,1
98,Monoamine GPCRs WP58,0.6686206881626044,1.0124458874458875,0.4075483101223271,['ADRA2C'],0.9997324946750447,0,0,1
99,Neural Crest Cell Migration during Development WP4564,0.6686206881626044,1.0124458874458875,0.4075483101223271,['EPHB3'],0.9997324946750447,0,0,1
100,Neural Crest Cell Migration in Cancer WP4565,0.6686206881626044,1.0124458874458875,0.4075483101223271,['EPHB3'],0.9997324946750447,0,0,1
101,Neural Crest Differentiation WP2064,0.6686206881626044,1.0124458874458875,0.4075483101223271,['MITF'],0.9997324946750447,0,0,1
102,Ovarian infertility WP34,0.6686206881626044,1.0124458874458875,0.4075483101223271,['EGR1'],0.9997324946750447,0,0,1
103,Phosphoinositides metabolism WP4971,0.6686206881626044,1.0124458874458875,0.4075483101223271,['PLCH1'],0.9997324946750447,0,0,1
104,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6686206881626044,1.0124458874458875,0.4075483101223271,['GSTP1'],0.9997324946750447,0,0,1
105,RANKL/RANK signaling pathway WP2018,0.6686206881626044,1.0124458874458875,0.4075483101223271,['MITF'],0.9997324946750447,0,0,1
106,Complement system WP2806,0.6726592596114918,0.8994938539407086,0.35666404524678064,"['RPS19', 'TXN']",0.9997324946750447,0,0,2
107,Endoderm differentiation WP2853,0.6726592596114918,0.8994938539407086,0.35666404524678064,"['PLCH1', 'NME1']",0.9997324946750447,0,0,2
108,Mesodermal commitment pathway WP2857,0.7202292216324925,0.8091106290672451,0.26553858208057396,"['RPL38', 'PLCH1']",0.9997324946750447,0,0,2
109,Retinoblastoma gene in cancer WP2446,0.7202292216324925,0.8091106290672451,0.26553858208057396,"['RRM2', 'H2AFZ']",0.9997324946750447,0,0,2
110,Androgen receptor signaling pathway WP138,0.7228480805130781,0.808695652173913,0.2624671899886533,"['BAG1', 'DSTN', 'PARK7']",0.9997324946750447,0,0,3
111,Alpha 6 Beta 4 signaling pathway WP244,0.7343849732633104,0.8095238095238095,0.2499177294845386,['LAMA3'],0.9997324946750447,0,0,1
112,AMP-activated protein kinase (AMPK) signaling WP1403,0.7343849732633104,0.8095238095238095,0.2499177294845386,['CCNA1'],0.9997324946750447,0,0,1
113,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7343849732633104,0.8095238095238095,0.2499177294845386,['LPL'],0.9997324946750447,0,0,1
114,Canonical and non-canonical Notch signaling WP3845,0.7343849732633104,0.8095238095238095,0.2499177294845386,['HEY1'],0.9997324946750447,0,0,1
115,White fat cell differentiation WP4149,0.7343849732633104,0.8095238095238095,0.2499177294845386,['DDIT3'],0.9997324946750447,0,0,1
116,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7343849732633104,0.8095238095238095,0.2499177294845386,['SLC38A2'],0.9997324946750447,0,0,1
117,Endochondral Ossification WP474,0.7343849732633104,0.8095238095238095,0.2499177294845386,['SLC38A2'],0.9997324946750447,0,0,1
118,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7343849732633104,0.8095238095238095,0.2499177294845386,['BANF1'],0.9997324946750447,0,0,1
119,G13 Signaling Pathway WP524,0.7343849732633104,0.8095238095238095,0.2499177294845386,['CFL2'],0.9997324946750447,0,0,1
120,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7343849732633104,0.8095238095238095,0.2499177294845386,['RRM2'],0.9997324946750447,0,0,1
121,Kit receptor signaling pathway WP304,0.7343849732633104,0.8095238095238095,0.2499177294845386,['MITF'],0.9997324946750447,0,0,1
122,Kynurenine Pathway and links to Cellular Senescence WP5044,0.7343849732633104,0.8095238095238095,0.2499177294845386,['NOS1'],0.9997324946750447,0,0,1
123,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.7343849732633104,0.8095238095238095,0.2499177294845386,['EIF1'],0.9997324946750447,0,0,1
124,Oxidative Damage WP3941,0.7343849732633104,0.8095238095238095,0.2499177294845386,['CYCS'],0.9997324946750447,0,0,1
125,p38 MAPK Signaling Pathway WP400,0.7343849732633104,0.8095238095238095,0.2499177294845386,['DDIT3'],0.9997324946750447,0,0,1
126,TGF-beta Signaling Pathway WP366,0.7618385188818919,0.7351607178071387,0.19997890603927915,"['PARD6A', 'CITED1']",0.9997324946750447,0,0,2
127,Corticotropin-releasing hormone signaling pathway WP2355,0.7618385188818919,0.7351607178071387,0.19997890603927915,"['IL18', 'FOSL2']",0.9997324946750447,0,0,2
128,3q29 copy number variation syndrome WP4906,0.7871204661054994,0.6742424242424242,0.16139608735648722,['NCBP2'],0.9997324946750447,0,0,1
129,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7871204661054994,0.6742424242424242,0.16139608735648722,['LPL'],0.9997324946750447,0,0,1
130,Common Pathways Underlying Drug Addiction WP2636,0.7871204661054994,0.6742424242424242,0.16139608735648722,['PPP1CC'],0.9997324946750447,0,0,1
131,DNA Replication WP466,0.7871204661054994,0.6742424242424242,0.16139608735648722,['POLD4'],0.9997324946750447,0,0,1
132,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7871204661054994,0.6742424242424242,0.16139608735648722,['CYCS'],0.9997324946750447,0,0,1
133,Folate Metabolism WP176,0.7871204661054994,0.6742424242424242,0.16139608735648722,['NOS1'],0.9997324946750447,0,0,1
134,IL-4 signaling pathway WP395,0.7871204661054994,0.6742424242424242,0.16139608735648722,['SOCS5'],0.9997324946750447,0,0,1
135,MET in type 1 papillary renal cell carcinoma WP4205,0.7871204661054994,0.6742424242424242,0.16139608735648722,['RPL11'],0.9997324946750447,0,0,1
136,Phosphodiesterases in neuronal function WP4222,0.7871204661054994,0.6742424242424242,0.16139608735648722,['NOS1'],0.9997324946750447,0,0,1
137,Cell cycle WP179,0.7889771091901404,0.7127877237851662,0.16894350003843556,"['CCNA1', 'PTTG1', 'ANAPC11']",0.9997324946750447,0,0,3
138,Ectoderm Differentiation WP2858,0.8294038602599576,0.577612863327149,0.10804137527835525,['PLCXD3'],0.9997324946750447,0,0,1
139,Glycogen Synthesis and Degradation WP500,0.8294038602599576,0.577612863327149,0.10804137527835525,['PHKA1'],0.9997324946750447,0,0,1
140,Hippo-Merlin Signaling Dysregulation WP4541,0.8294038602599576,0.577612863327149,0.10804137527835525,['PPP1CC'],0.9997324946750447,0,0,1
141,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8294038602599576,0.577612863327149,0.10804137527835525,['IFI27L2'],0.9997324946750447,0,0,1
142,Notch Signaling Pathway Netpath WP61,0.8294038602599576,0.577612863327149,0.10804137527835525,['HEY1'],0.9997324946750447,0,0,1
143,Photodynamic therapy-induced unfolded protein response WP3613,0.8294038602599576,0.577612863327149,0.10804137527835525,['DDIT3'],0.9997324946750447,0,0,1
144,Vitamin D Receptor Pathway WP2877,0.841462859606452,0.637070938215103,0.10996698212968166,"['CEACAM1', 'NINJ1', 'S100A6']",0.9997324946750447,0,0,3
145,Translation Factors WP107,0.8559696937546396,0.5766966222497676,0.08968803629142515,"['EEF1B2', 'EIF1']",0.9997324946750447,0,0,2
146,Male infertility WP4673,0.8559696937546396,0.5766966222497676,0.08968803629142515,"['CCNA1', 'NOS1']",0.9997324946750447,0,0,2
147,Regulation of Actin Cytoskeleton WP51,0.8559696937546396,0.5766966222497676,0.08968803629142515,"['CFL2', 'BRK1']",0.9997324946750447,0,0,2
148,Senescence and Autophagy in Cancer WP615,0.8631959628126994,0.6048913043478261,0.08898770233796982,"['GABARAPL2', 'GABARAPL1', 'GABARAP']",0.9997324946750447,0,0,3
149,EGF/EGFR signaling pathway WP437,0.8631959628126994,0.6048913043478261,0.08898770233796982,"['NDUFA13', 'NEDD8', 'FOXO4']",0.9997324946750447,0,0,3
150,Sleep regulation WP3591,0.863303146384516,0.5051406926406926,0.0742503167925116,['IL18'],0.9997324946750447,0,0,1
151,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.863303146384516,0.5051406926406926,0.0742503167925116,['RNF7'],0.9997324946750447,0,0,1
152,Synaptic Vesicle Pathway WP2267,0.863303146384516,0.5051406926406926,0.0742503167925116,['PARK7'],0.9997324946750447,0,0,1
153,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.863303146384516,0.5051406926406926,0.0742503167925116,['NDRG1'],0.9997324946750447,0,0,1
154,Small cell lung cancer WP4658,0.8788753503905864,0.5379609544468547,0.06945732222550777,"['LAMA3', 'CYCS']",0.9997324946750447,0,0,2
155,Aryl Hydrocarbon Receptor Netpath WP2586,0.8904778672898538,0.44877344877344877,0.052056387564926504,['LPL'],0.9997324946750447,0,0,1
156,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8904778672898538,0.44877344877344877,0.052056387564926504,['NOS1'],0.9997324946750447,0,0,1
157,Insulin Signaling WP481,0.8983787018297142,0.5040672451193059,0.05401765186734496,"['EHD1', 'EGR1']",0.9997324946750447,0,0,2
158,Apoptosis WP254,0.912259649410244,0.4036796536796537,0.03707015535229202,['CYCS'],0.9997324946750447,0,0,1
159,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.912259649410244,0.4036796536796537,0.03707015535229202,['EGR1'],0.9997324946750447,0,0,1
160,DNA damage response WP707,0.912259649410244,0.4036796536796537,0.03707015535229202,['CYCS'],0.9997324946750447,0,0,1
161,Glucocorticoid Receptor Pathway WP2880,0.912259649410244,0.4036796536796537,0.03707015535229202,['TSC22D3'],0.9997324946750447,0,0,1
162,Leptin signaling pathway WP2034,0.912259649410244,0.4036796536796537,0.03707015535229202,['CFL2'],0.9997324946750447,0,0,1
163,miRNA regulation of DNA damage response WP1530,0.912259649410244,0.4036796536796537,0.03707015535229202,['CYCS'],0.9997324946750447,0,0,1
164,Oncostatin M Signaling Pathway WP2374,0.912259649410244,0.4036796536796537,0.03707015535229202,['EGR1'],0.9997324946750447,0,0,1
165,7q11.23 copy number variation syndrome WP4932,0.914925880447339,0.47416103100676277,0.042158710835211805,"['ATP5F1E', 'ATP5MC1']",0.9997324946750447,0,0,2
166,Adipogenesis WP236,0.914925880447339,0.47416103100676277,0.042158710835211805,"['DDIT3', 'LPL']",0.9997324946750447,0,0,2
167,Apoptosis Modulation and Signaling WP1772,0.9289201325248548,0.4475777295733912,0.033001031799082446,"['ENDOG', 'CYCS']",0.9997324946750447,0,0,2
168,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9297168841053626,0.36678473042109405,0.02672949770303358,['CYCS'],0.9997324946750447,0,0,1
169,Glioblastoma signaling pathways WP2261,0.9297168841053626,0.36678473042109405,0.02672949770303358,['FOXO4'],0.9997324946750447,0,0,1
170,"GPCRs, Other WP117",0.9297168841053626,0.36678473042109405,0.02672949770303358,['GPR162'],0.9997324946750447,0,0,1
171,Metabolic reprogramming in colon cancer WP4290,0.9297168841053626,0.36678473042109405,0.02672949770303358,['SLC16A3'],0.9997324946750447,0,0,1
172,Non-small cell lung cancer WP4255,0.9297168841053626,0.36678473042109405,0.02672949770303358,['CYCS'],0.9997324946750447,0,0,1
173,16p11.2 proximal deletion syndrome WP4949,0.9437066730549897,0.336038961038961,0.01947006004127331,['SEZ6L2'],0.9997324946750447,0,0,1
174,Exercise-induced Circadian Regulation WP410,0.9437066730549897,0.336038961038961,0.01947006004127331,['GSTP1'],0.9997324946750447,0,0,1
175,Nuclear Receptors Meta-Pathway WP2882,0.9477512556983961,0.5277522408641692,0.028320873872930138,"['EGR1', 'TSC22D3', 'GSTP1', 'TXN', 'SLC5A3']",0.9997324946750447,0,0,5
176,Spinal Cord Injury WP2431,0.9506470671713967,0.40238611713665945,0.020365728285292213,"['EGR1', 'NOS1']",0.9997324946750447,0,0,2
177,Gastrin signaling pathway WP4659,0.9506470671713967,0.40238611713665945,0.020365728285292213,"['CHGA', 'EGR1']",0.9997324946750447,0,0,2
178,Wnt signaling pathway and pluripotency WP399,0.9549165407917225,0.31002331002331,0.014301788912516225,['ZBTB33'],0.9997324946750447,0,0,1
179,G1 to S cell cycle control WP45,0.9549165407917225,0.31002331002331,0.014301788912516225,['CCNA1'],0.9997324946750447,0,0,1
180,Focal Adhesion WP306,0.9589756915933295,0.383018283235203,0.016044464323448207,"['PPP1CC', 'LAMA3']",0.9997324946750447,0,0,2
181,Circadian rhythm related genes WP3594,0.9613683425633737,0.43020186335403726,0.016948943534578764,"['EGR1', 'PPP1CC', 'RPS27A']",0.9997324946750447,0,0,3
182,TNF-alpha signaling pathway WP231,0.9638979269733834,0.28772418058132343,0.010579582114221288,['TXN'],0.9997324946750447,0,0,1
183,Proximal tubule transport WP4917,0.9638979269733834,0.28772418058132343,0.010579582114221288,['SLC7A9'],0.9997324946750447,0,0,1
184,Ras signaling WP4223,0.9638979269733834,0.28772418058132343,0.010579582114221288,['FOXO4'],0.9997324946750447,0,0,1
185,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9710930751580629,0.2683982683982684,0.00787291576035711,['MMP15'],0.9997324946750447,0,0,1
186,Melanoma WP4685,0.9710930751580629,0.2683982683982684,0.00787291576035711,['MITF'],0.9997324946750447,0,0,1
187,Metapathway biotransformation Phase I and II WP702,0.9710930751580629,0.2683982683982684,0.00787291576035711,['GSTP1'],0.9997324946750447,0,0,1
188,Hepatitis B infection WP4666,0.9768566182829306,0.25148809523809523,0.005888693047640038,['CYCS'],0.9997324946750447,0,0,1
189,Osteoblast differentiation WP4787,0.9768566182829306,0.25148809523809523,0.005888693047640038,['HEY1'],0.9997324946750447,0,0,1
190,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9768566182829306,0.25148809523809523,0.005888693047640038,['PSMD7'],0.9997324946750447,0,0,1
191,Myometrial relaxation and contraction pathways WP289,0.9803611674320479,0.3756114130434783,0.007449965791870727,"['ACTA2', 'ACTC1', 'NOS1']",0.9997324946750447,0,0,3
192,"GPCRs, Class A Rhodopsin-like WP455",0.9806821207349282,0.3210412147505423,0.00626252140049017,"['GPR12', 'ADRA2C']",0.9997324946750447,0,0,2
193,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9923985008043985,0.19109461966604824,0.001458154726836409,['EGR1'],0.9997324946750447,0,0,1
194,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9939176692593455,0.18231011412829595,0.0011122564066002294,['EGR1'],0.9997324946750447,0,0,1
195,Breast cancer pathway WP4262,0.995133651803364,0.17428947863730473,0.0008502237143440473,['HEY1'],0.9997324946750447,0,0,1
196,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9959309372836501,0.24216130940642872,0.0009873797757027646,"['LAMA3', 'NOS1']",0.9997324946750447,0,0,2
197,MAPK Signaling Pathway WP382,0.9975088233976533,0.15392940392940394,0.0003839437641524168,['DDIT3'],0.9997324946750447,0,0,1
198,Calcium Regulation in the Cardiac Cell WP536,0.9980074060985324,0.14814814814814814,0.0002954935937473848,['GJD2'],0.9997324946750447,0,0,1
199,PI3K-Akt signaling pathway WP4172,0.9997324946750447,0.11056998556998557,2.9582016770139692e-05,['LAMA3'],0.9997324946750447,0,0,1
